We are delighted to announce that Paul Corris, PVRI President 2016/17, will be awarded this year's prestigious British Thoracic Society Medal.
The BTS Medal is awarded annually to a distinguished physician who has greatly contributed to respiratory medicine or science. This highly regarded award aims to acknowledge the recipient’s leadership in, and contribution to, clinical and/or scientific work which has resulted in benefit to patients and has provided the inspiration of peers. Previous winners have included many other pioneers in respiratory medicine.
Paul, who was fundamental to the development of the UK pulmonary hypertension service in 2001, has been a visionary leader in the field throughout his distinguished career. Paul played a major role in developing the Academic Department of Respiratory Medicine at Newcastle University and directed the department until handing over to Professor John Simpson and Professor Andrew Fisher. After his appointment in Newcastle, he played a pioneering role in developing lung transplantation from an experimental procedure to clinical mainstream helping to establish Newcastle as a centre with an international reputation in this field. He is a previous Director of the Cardiopulmonary Transplant Service and Academic Director of the Institute of Transplantation, Newcastle.
Paul has been pivotal in uniquely positioning himself as a ‘trusted broker’ between a wide range of diverse people and organisations acting as a catalyst for non-hierarchical dialogue across multiple boundaries. From an international perspective, his tenure as PVRI President saw the Institute widen its international reach and impact on improving global health. He developed a new e-learning initiative, which is aimed at bringing knowledge and education on PVD to clinicians who are working in isolated and geographically remote areas of the world.
Despite having finished his two year term as the PVRI President, Paul continues to have a lasting positive impact on the activities of our organisation through his involvement in the rapidly expanding Innovation Drug Development Initiative (IDDI), the second phase of the PVRI Digital Clinic and his contributions in global health.